Recombinant Human Superoxide Dismutase Enhances the Effect of Inhaled Nitric Oxide in Persistent Pulmonary Hypertension
Robin H. Steinhorn(Children's National), Jonathan M. Davis(Westat (United States)), George Albert(University of Rochester Medical Center), Daniel D. Swartz(Northwestern University), James A. Russell(University of British Columbia), Carolyn Robbins Levine(Northwestern University)
American Journal of Respiratory and Critical Care Medicine
September 1, 2001
Cited by 93
Related Papers
Pediatric Pulmonary Hypertension
|Circulation|2015|1.1k
Severe Coronavirus Disease-2019 in Children and Young Adults in the Washington, DC, Metropolitan Region
|The Journal of Pediatrics|2020|373
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy
|JAMA|2019|370
Inhaled Nitric Oxide for Premature Infants with Severe Respiratory Failure
|New England Journal of Medicine|2005|306
Intravenous Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension
|The Journal of Pediatrics|2009|240